# Weekly Brief (Example)

**Top Stories**
1. FDA clears next-gen transcatheter mitral valve system (Abbott) — Relevance 92, Urgency: Breaking. *Action:* Prep quote on surgical implications and readiness for hybrid programs.
2. NEJM publishes multicenter trial on minimally invasive aortic repair showing 15% shorter LOS — Relevance 85. *Action:* Draft commentary comparing with WVU outcomes and Badhwar procedural volume.

**Competitor Watch**
- Cleveland Clinic announces 500th robotic mitral case with 1.2% 30-day mortality — Relevance 78. *Action:* Update competitive positioning deck; monitor media pickup.

**Research Radar**
- Circulation: New meta-analysis links frailty index to post-op AFib risk — Relevance 73. *Action:* Flag for grand rounds; consider op-ed on perioperative optimization.

**Opportunities**
- STS 2025 call for late-breaking abstracts closes in 3 weeks — Relevance 80, Urgency: Routine. *Action:* Coordinate submission on minimally invasive outcomes dataset.

**30-day Look-Ahead**
- FDA advisory panel on structural heart devices (Sep 5)
- CMS proposed rule comment deadline on cardiac DRGs (Sep 12)

**Editorial Checks**
- AI-generated draft; requires human approval.
- Facts verified against linked sources; no patient identifiers.
